Zentek (ZTEK) Operating Margin (2021 - 2026)
Zentek (ZTEK) posted quarterly Operating Margin of 9450.59% for Q1 2026, down 716474.0% year-on-year from N/an in Q1 2025, and down 119.25% on a QoQ basis from 4310.44% in Q4 2025.
Zentek (ZTEK) Operating Margin (2021 - 2026) Analysis & Trends
Zentek (ZTEK) has reported Operating Margin for 6 consecutive years, with 9450.59% the latest figure, recorded in Q1 2026.
- Quarterly Operating Margin fell 716474.0% year-over-year to 9450.59% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6379.99% (down 444527.0% YoY) and the FY2026 annual result came in at 6611.72%, down 551081.0% from the prior year.
- Operating Margin retreated to 9450.59% in Q1 2026 per ZTEK's latest filing, from 4310.44% in the prior quarter.
- Over the last five years, Operating Margin for ZTEK reached as high as 63553.98% in Q4 2023 and fell as low as 298995.94% in Q1 2023.
- A 5-year average of 14144.75% and a median of 2724.19% in 2025 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2023 — Operating Margin slumped 5454858 bps — and 2024, when it soared 29510419 bps.
- Year by year, Operating Margin stood at 33245.25% in 2022, then jumped by 91 bps to 63553.98% in 2023, then tumbled by 50 bps to 31966.93% in 2024, then tumbled by 113 bps to 4310.44% in 2025, then sank by 119 bps to 9450.59% in 2026.
- According to Business Quant data, Operating Margin over the past three periods registered 9450.59%, 4310.44%, and 39379.42% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 98.77% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 33.60% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 1.97% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 5.74% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 34.92% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 20.53% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -2.87% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.04% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 13.65% |
| 10 | Zentek | 57.20 Mn | 56.25 Mn | -979,642.64 | -9,450.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,450.59% |
| Dec 31, 2025 | -4,310.44% |
| Sep 30, 2025 | -39,379.42% |
| Jun 30, 2025 | -3,162.53% |
| Mar 31, 2025 | -2,285.84% |
| Dec 31, 2024 | 31,966.93% |
| Sep 30, 2024 | 14,873.09% |
| Jun 30, 2024 | -46,776.90% |
| Mar 31, 2024 | -3,891.75% |
| Dec 31, 2023 | 63,553.98% |
| Sep 30, 2023 | 30,198.47% |
| Jun 30, 2023 | -54,673.79% |
| Mar 31, 2023 | -298,995.94% |
| Dec 31, 2022 | 33,245.25% |
| Sep 30, 2022 | 62,898.66% |
| Jun 30, 2022 | -125.22% |
| Dec 31, 2021 | 4,006.22% |
| Sep 30, 2021 | -630.16% |